PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: stock market

GUIDANCE FOR INDUSTRY

G U I D ANC E F O R INDU S T R Y POST-MARKETING VIGILANCE REQUIREMENTS FOR THERAPEUTIC PRODUCTS AND CELL, TISSUE AND GENE THERAPY PRODUCTS 01 MARCH 2021 2016 GUIDANCE for INDUSTRY Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP 01 March 2021 2 PREFACE This document is intended to provide general GUIDANCE . Although we have tried to ensure that the information contained here is accurate, we do not, however, warrant its accuracy or completeness. The Health Sciences Authority (HSA) accepts no liability for any errors or omissions in this document, or for any action / decision taken or not taken as a result of using this document. If you need specific legal or professional advice, you should consult your own legal or other relevant professional advisers.

Guidance for Industry – Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP 01 March 2021 2 PREFACE This document is intended to provide general guidance. Although we have tried to ensure that the information contained here is accurate, we do not, however, warrant

Loading..

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of GUIDANCE FOR INDUSTRY

Related search queries